High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1869, Issue 2, 2018, Pages 216-229

  Sgarra, Riccardo ^a   Pegoraro, Silvia ^a   Ros, Gloria ^a   Penzo, Carlotta ^a   Chiefari, Eusebio ^b   Foti, Daniela ^b   Brunetti, Antonio ^b   Manfioletti, Guidalberto ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Architectural transcription factors; Breast cancer; Cancer heterogeneity; Chromatin; HMGA

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HIGH MOBILITY GROUP A1A PROTEIN; HIGH MOBILITY GROUP A1B PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; MICRORNA 33B; MICRORNA 93; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; TUMOR MARKER;

BREAST CANCER; CANCER AGGRESSIVENESS; CANCER GROWTH; CANCER PROGNOSIS; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; DNA REPAIR; GENE EXPRESSION PROFILING; ONCOLOGICAL PARAMETERS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOGENE; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; BREAST TUMOR; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN ASSEMBLY AND DISASSEMBLY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA PROTEINS; HUMANS; PROGNOSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 85043569254     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2018.03.001     Document Type: Review

References (146)

1. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J. Clin. 65 (2015), 87–108.
2. Dai, X., Li, T., Bai, Z., Yang, Y., Liu, X., Zhan, J., Shi, B., Breast cancer intrinsic subtype classification, clinical use and future trends. Am. J. Cancer Res. 5 (2015), 2929–2943.
3. Simpson, P.T., Reis-Filho, J.S., Gale, T., Lakhani, S.R., Molecular evolution of breast cancer. J. Pathol. 205 (2005), 248–254.
4. Gu, G., Dustin, D., Fuqua, S.A., Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment. Curr. Opin. Pharmacol. 31 (2016), 97–103.
5. Moran, M.S., Radiation therapy in the locoregional treatment of triple-negative breast cancer. The Lancet Oncol. 16 (2015), e113–122.
6. Sorlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Thorsen, T., Quist, H., Matese, J.C., Brown, P.O., Botstein, D., Eystein Lonning, P., Borresen-Dale, A.L., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 10869–10874.
7. Gatza, M.L., Lucas, J.E., Barry, W.T., Kim, J.W., Wang, Q., Crawford, M.D., Datto, M.B., Kelley, M., Mathey-Prevot, B., Potti, A., Nevins, J.R., A pathway-based classification of human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 6994–6999.
8. Nwabo Kamdje, A.H., Seke Etet, P.F., Vecchio, L., Tagne, R.S., Amvene, J.M., Muller, J.M., Krampera, M., Lukong, K.E., New targeted therapies for breast cancer: a focus on tumor microenvironmental signals and chemoresistant breast cancers. World Journal of Clinical Cases 2 (2014), 769–786.
9. Lehmann, B.D., Bauer, J.A., Chen, X., Sanders, M.E., Chakravarthy, A.B., Shyr, Y., Pietenpol, J.A., Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121 (2011), 2750–2767.
10. Reeves, R., Nuclear functions of the HMG proteins. Biochim. Biophys. Acta 1799 (2010), 3–14.
11. Sgarra, R., Rustighi, A., Tessari, M.A., Di Bernardo, J., Altamura, S., Fusco, A., Manfioletti, G., Giancotti, V., Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett. 574 (2004), 1–8.
12. Sgarra, R., Zammitti, S., Lo Sardo, A., Maurizio, E., Arnoldo, L., Pegoraro, S., Giancotti, V., Manfioletti, G., HMGA molecular network: from transcriptional regulation to chromatin remodeling. Biochim. Biophys. Acta 1799 (2010), 37–47.
13. Fusco, A., Fedele, M., Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7 (2007), 899–910.
14. Sumter, T.F., Xian, L., Huso, T., Koo, M., Chang, Y.T., Almasri, T.N., Chia, L., Inglis, C., Reid, D., Resar, L.M., The high mobility group A1 (HMGA1) transcriptome in cancer and development. Curr. Mol. Med. 16 (2016), 353–393.
15. Munshi, N., Agalioti, T., Lomvardas, S., Merika, M., Chen, G., Thanos, D., Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293 (2001), 1133–1136.
16. Kishi, Y., Fujii, Y., Hirabayashi, Y., Gotoh, Y., HMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells. Nat. Neurosci. 15 (2012), 1127–1133.
17. Singh, I., Ozturk, N., Cordero, J., Mehta, A., Hasan, D., Cosentino, C., Sebastian, C., Kruger, M., Looso, M., Carraro, G., Bellusci, S., Seeger, W., Braun, T., Mostoslavsky, R., Barreto, G., High mobility group protein-mediated transcription requires DNA damage marker gamma-H2AX. Cell Res. 25 (2015), 837–850.
18. Mantovani, F., Covaceuszach, S., Rustighi, A., Sgarra, R., Heath, C., Goodwin, G.H., Manfioletti, G., NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C. Nucleic Acids Res. 26 (1998), 1433–1439.
19. Palmieri, D., Valentino, T., De Martino, I., Esposito, F., Cappabianca, P., Wierinckx, A., Vitiello, M., Lombardi, G., Colao, A., Trouillas, J., Pierantoni, G.M., Fusco, A., Fedele, M., PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. Endocr. Relat. Cancer 19 (2012), 123–135.
20. De Martino, I., Visone, R., Wierinckx, A., Palmieri, D., Ferraro, A., Cappabianca, P., Chiappetta, G., Forzati, F., Lombardi, G., Colao, A., Trouillas, J., Fedele, M., Fusco, A., HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. 69 (2009), 1844–1850.
21. Sgarra, R., Tessari, M.A., Di Bernardo, J., Rustighi, A., Zago, P., Liberatori, S., Armini, A., Bini, L., Giancotti, V., Manfioletti, G., Discovering high mobility group A molecular partners in tumour cells. Proteomics 5 (2005), 1494–1506.
22. Sgarra, R., Furlan, C., Zammitti, S., Lo Sardo, A., Maurizio, E., Di Bernardo, J., Giancotti, V., Manfioletti, G., Interaction proteomics of the HMGA chromatin architectural factors. Proteomics 8 (2008), 4721–4732.
23. Zhou, X., Benson, K.F., Ashar, H.R., Chada, K., Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376 (1995), 771–774.
24. Fedele, M., Fidanza, V., Battista, S., Pentimalli, F., Klein-Szanto, A.J., Visone, R., De Martino, I., Curcio, A., Morisco, C., Del Vecchio, L., Baldassarre, G., Arra, C., Viglietto, G., Indolfi, C., Croce, C.M., Fusco, A., Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res. 66 (2006), 2536–2543.
25. Ogram, S.A., Reeves, R., Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene. J. Biol. Chem. 270 (1995), 14235–14242.
26. Holth, L.T., Thorlacius, A.E., Reeves, R., Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines. DNA Cell Biol. 16 (1997), 1299–1309.
27. Akaboshi, S., Watanabe, S., Hino, Y., Sekita, Y., Xi, Y., Araki, K., Yamamura, K., Oshima, M., Ito, T., Baba, H., Nakao, M., HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. Am. J. Pathol. 175 (2009), 1675–1685.
28. Wood, L.J., Mukherjee, M., Dolde, C.E., Xu, Y., Maher, J.F., Bunton, T.E., Williams, J.B., Resar, L.M., HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol. Cell. Biol. 20 (2000), 5490–5502.
29. Cleynen, I., Huysmans, C., Sasazuki, T., Shirasawa, S., Van de Ven, W., Peeters, K., Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression. Cancer Res. 67 (2007), 4620–4629.
30. Massimi, I., Guerrieri, F., Petroni, M., Veschi, V., Truffa, S., Screpanti, I., Frati, L., Levrero, M., Gulino, A., Giannini, G., The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1. Mol. Carcinog. 52 (2013), 526–534.
31. Zu, X., Zhong, J., Tan, J., Tan, L., Yang, D., Zhang, Q., Ding, W., Liu, W., Wen, G., Liu, J., Cao, R., Jiang, Y., TGF-beta1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-beta signaling. Int. J. Mol. Med. 35 (2015), 693–701.
32. Chiefari, E., Arcidiacono, B., Possidente, K., Iiritano, S., Ventura, V., Pandolfo, R., Brunetti, F.S., Greco, M., Foti, D., Brunetti, A., Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2. PLoS One, 8, 2013, e83969.
33. Qian, X., Zhao, F.Q., Regulatory roles of Oct proteins in the mammary gland. Biochim. Biophys. Acta 1859 (2016), 812–819.
34. Tallini, G., Dal Cin, P., HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv. Anat. Pathol. 6 (1999), 237–246.
35. Chau, K., Arlotta, P., Patel, U.A., Crane-Robinson, C., Manfioletti, G., Ono, S.J., A novel downstream positive regulatory element mediating transcription of the human high mobility group (HMG) I-C gene. FEBS Lett. 457 (1999), 429–436.
36. Rustighi, A., Mantovani, F., Fusco, A., Giancotti, V., Manfioletti, G., Sp1 and CTF/NF-1 transcription factors are involved in the basal expression of the Hmgi-c proximal promoter. Biochem. Biophys. Res. Commun. 265 (1999), 439–447.
37. Ayoubi, T.A., Jansen, E., Meulemans, S.M., Van de Ven, W.J., Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development. Oncogene 18 (1999), 5076–5087.
38. Thuault, S., Valcourt, U., Petersen, M., Manfioletti, G., Heldin, C.H., Moustakas, A., Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174 (2006), 175–183.
39. Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M., Jardon, M., Hardie, N., Loddenkemper, C., Ulasov, I., Lesniak, M.S., Wolsky, R., Bentolila, L.A., Grant, S.G., Elashoff, D., Lehr, S., Latimer, J.J., Bose, S., Sattar, H., Krum, S.A., Miranda-Carboni, G.A., WNT10B/beta-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer. EMBO Molecular Medicine 5 (2013), 264–279.
40. Lam, K., Muselman, A., Du, R., Harada, Y., Scholl, A.G., Yan, M., Matsuura, S., Weng, S., Harada, H., Zhang, D.E., Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice. Blood 124 (2014), 2203–2212.
41. Hong, D., Park, M.J., Jang, E.H., Jung, B., Kim, N.J., Kim, J.H., Hispolon as an inhibitor of TGF-beta-induced epithelial-mesenchymal transition in human epithelial cancer cells by co-regulation of TGF-beta-Snail/Twist axis. Oncol. Lett. 14 (2017), 4866–4872.
42. Boque-Sastre, R., Soler, M., Oliveira-Mateos, C., Portela, A., Moutinho, C., Sayols, S., Villanueva, A., Esteller, M., Guil, S., Head-to-head antisense transcription and R-loop formation promotes transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 5785–5790.
43. D'Angelo, D., Esposito, F., Fusco, A., Epigenetic mechanisms leading to overexpression of HMGA proteins in human pituitary adenomas. Frontiers in Medicine, 2, 2015, 39.
44. Bussing, I., Slack, F.J., Grosshans, H., Let-7 microRNAs in development, stem cells and cancer. Trends Mol. Med. 14 (2008), 400–409.
45. Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., Song, E., Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007), 1109–1123.
46. Lee, Y.S., Dutta, A., The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21 (2007), 1025–1030.
47. Mayr, C., Hemann, M.T., Bartel, D.P., Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007), 1576–1579.
48. Park, S.M., Shell, S., Radjabi, A.R., Schickel, R., Feig, C., Boyerinas, B., Dinulescu, D.M., Lengyel, E., Peter, M.E., Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6 (2007), 2585–2590.
49. Shell, S., Park, S.M., Radjabi, A.R., Schickel, R., Kistner, E.O., Jewell, D.A., Feig, C., Lengyel, E., Peter, M.E., Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 11400–11405.
50. Dangi-Garimella, S., Yun, J., Eves, E.M., Newman, M., Erkeland, S.J., Hammond, S.M., Minn, A.J., Rosner, M.R., Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 28 (2009), 347–358.
51. Yun, J., Frankenberger, C.A., Kuo, W.L., Boelens, M.C., Eves, E.M., Cheng, N., Liang, H., Li, W.H., Ishwaran, H., Minn, A.J., Rosner, M.R., Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J. 30 (2011), 4500–4514.
52. Sun, M., Gomes, S., Chen, P., Frankenberger, C.A., Sankarasharma, D., Chung, C.H., Chada, K.K., Rosner, M.R., RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2. Oncogene 33 (2014), 3528–3537.
53. Zou, Q., Wu, H., Fu, F., Yi, W., Pei, L., Zhou, M., RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2. Arch. Biochem. Biophys. 610 (2016), 25–32.
54. Frankenberger, C., Rabe, D., Bainer, R., Sankarasharma, D., Chada, K., Krausz, T., Gilad, Y., Becker, L., Rosner, M.R., Metastasis suppressors regulate the tumor microenvironment by blocking recruitment of prometastatic tumor-associated macrophages. Cancer Res. 75 (2015), 4063–4073.
55. Guo, L., Chen, C., Shi, M., Wang, F., Chen, X., Diao, D., Hu, M., Yu, M., Qian, L., Guo, N., Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene 32 (2013), 5272–5282.
56. Lin, Y., Liu, A.Y., Fan, C., Zheng, H., Li, Y., Zhang, C., Wu, S., Yu, D., Huang, Z., Liu, F., Luo, Q., Yang, C.J., Ouyang, G., MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci. Rep., 5, 2015, 9995.
57. Liu, S., Patel, S.H., Ginestier, C., Ibarra, I., Martin-Trevino, R., Bai, S., McDermott, S.P., Shang, L., Ke, J., Ou, S.J., Heath, A., Zhang, K.J., Korkaya, H., Clouthier, S.G., Charafe-Jauffret, E., Birnbaum, D., Hannon, G.J., Wicha, M.S., MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet., 8, 2012, e1002751.
58. Liu, K., Zhang, C., Li, T., Ding, Y., Tu, T., Zhou, F., Qi, W., Chen, H., Sun, X., Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1. Int. J. Oncol. 46 (2015), 2526–2534.
59. Zhou, W.B., Zhong, C.N., Luo, X.P., Zhang, Y.Y., Zhang, G.Y., Zhou, D.X., Liu, L.P., miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer. Biochem. Biophys. Res. Commun. 470 (2016), 838–844.
60. Zhao, X.X., Yuan, Q.Z., Mu, D.P., Sun, D.W., Bo, Q.A., Pan, G.Z., Li, G.Q., Cui, T., Ding, P.P., You, F.P., Hao, L., Wang, M.X., Zhang, J., MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer. Int. J. Clin. Exp. Pathol. 8 (2015), 368–373.
61. Liang, H., Gu, Y., Li, T., Zhang, Y., Huangfu, L., Hu, M., Zhao, D., Chen, Y., Liu, S., Dong, Y., Li, X., Lu, Y., Yang, B., Shan, H., Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis., 5, 2014, e1238.
62. Zhou, H., Guo, W., Zhao, Y., Wang, Y., Zha, R., Ding, J., Liang, L., Hu, J., Shen, H., Chen, Z., Yin, B., Ma, B., MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2. Int. J. Oncol. 44 (2014), 2050–2058.
63. Kaddar, T., Rouault, J.P., Chien, W.W., Chebel, A., Gadoux, M., Salles, G., Ffrench, M., Magaud, J.P., Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol. Cell. 101 (2009), 511–524.
64. De Martino, M., Forzati, F., Marfella, M., Pellecchia, S., Arra, C., Terracciano, L., Fusco, A., Esposito, F., HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism. Sci. Rep., 6, 2016, 37622.
65. Esposito, F., De Martino, M., D'Angelo, D., Mussnich, P., Raverot, G., Jaffrain-Rea, M.L., Fraggetta, F., Trouillas, J., Fusco, A., HMGA1-pseudogene expression is induced in human pituitary tumors. Cell Cycle 14 (2015), 1471–1475.
66. Esposito, F., De Martino, M., Petti, M.G., Forzati, F., Tornincasa, M., Federico, A., Arra, C., Pierantoni, G.M., Fusco, A., HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget 5 (2014), 8341–8354.
67. Esposito, F., De Martino, M., Forzati, F., Fusco, A., HMGA1-pseudogene overexpression contributes to cancer progression. Cell Cycle 13 (2014), 3636–3639.
68. Borrmann, L., Wilkening, S., Bullerdiek, J., The expression of HMGA genes is regulated by their 3'UTR. Oncogene 20 (2001), 4537–4541.
69. Kristjansdottir, K., Fogarty, E.A., Grimson, A., Systematic analysis of the Hmga2 3'UTR identifies many independent regulatory sequences and a novel interaction between distal sites. RNA 21 (2015), 1346–1360.
70. Wang, Y., Chen, F., Yang, Z., Zhao, M., Zhang, S., Gao, Y., Feng, J., Yang, G., Zhang, W., Ye, L., Zhang, X., The fragment HMGA2-sh-3p20 from HMGA2 mRNA 3'UTR promotes the growth of hepatoma cells by upregulating HMGA2. Sci. Rep., 7, 2017, 2070.
71. Rogalla, P., Drechsler, K., Kazmierczak, B., Rippe, V., Bonk, U., Bullerdiek, J., Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol. Carcinog. 19 (1997), 153–156.
72. Ryu, J.W., Kim, D.H., Shin, H.S., Nam, E.S., Kim, H.J., Expression of high mobility group protein family [HMGI(Y) and HMGI-C] in human breast cancer. Cancer Research and Treatment: Official Journal of Korean Cancer Association 33 (2001), 281–285.
73. Pegoraro, S., Ros, G., Piazza, S., Sommaggio, R., Ciani, Y., Rosato, A., Sgarra, R., Del Sal, G., Manfioletti, G., HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget 4 (2013), 1293–1308.
74. Chiappetta, G., Botti, G., Monaco, M., Pasquinelli, R., Pentimalli, F., Di Bonito, M., D'Aiuto, G., Fedele, M., Iuliano, R., Palmieri, E.A., Pierantoni, G.M., Giancotti, V., Fusco, A., HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. Clin. Cancer Res. 10 (2004), 7637–7644.
75. Chiappetta, G., Ottaiano, A., Vuttariello, E., Monaco, M., Galdiero, F., Gallipoli, A., Pilotti, S., Jodice, G., Siranoush, M., Colombo, M., Ripamonti, C.B., Pallante, P.L., Radice, P., Fusco, A., HMGA1 protein expression in familial breast carcinoma patients. Eur. J. Cancer 46 (2010), 332–339.
76. Flohr, A.M., Rogalla, P., Bonk, U., Puettmann, B., Buerger, H., Gohla, G., Packeisen, J., Wosniok, W., Loeschke, S., Bullerdiek, J., High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol. Histopathol. 18 (2003), 999–1004.
77. Huang, R., Huang, D., Dai, W., Yang, F., Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer. Mol. Cell. Biochem. 404 (2015), 251–257.
78. Sepe, R., Piscuoglio, S., Quintavalle, C., Perrina, V., Quagliata, L., Formisano, U., Terracciano, L.M., Fusco, A., Pallante, P., HMGA1 overexpression is associated with a particular subset of human breast carcinomas. J. Clin. Pathol. 69 (2016), 117–121.
79. Wu, J., Zhang, S., Shan, J., Hu, Z., Liu, X., Chen, L., Ren, X., Yao, L., Sheng, H., Li, L., Ann, D., Yen, Y., Wang, J., Wang, X., Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer. Cancer Lett. 376 (2016), 284–292.
80. Treff, N.R., Pouchnik, D., Dement, G.A., Britt, R.L., Reeves, R., High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells. Oncogene 23 (2004), 777–785.
81. Kallen, A.N., Zhou, X.B., Xu, J., Qiao, C., Ma, J., Yan, L., Lu, L., Liu, C., Yi, J.S., Zhang, H., Min, W., Bennett, A.M., Gregory, R.I., Ding, Y., Huang, Y., The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 52 (2013), 101–112.
82. Liu, D., Deng, Q., Sun, L., Wang, T., Yang, Z., Chen, H., Guo, L., Liu, Y., Ma, Y., Guo, N., Shi, M., A Her2-let-7-beta2-AR circuit affects prognosis in patients with Her2-positive breast cancer. BMC Cancer, 15, 2015, 832.
83. Langelotz, C., Schmid, P., Jakob, C., Heider, U., Wernecke, K.D., Possinger, K., Sezer, O., Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer. Br. J. Cancer 88 (2003), 1406–1410.
84. Sezer, O., Langelotz, C., Blohmer, J.U., Schmid, P., Akrivakis, K., Possinger, K., Detection of HMGI-C in the peripheral blood of breast cancer patients. Eur. J. Cancer 36 (2000), 1944–1948.
85. Fabjani, G., Tong, D., Wolf, A., Roka, S., Leodolter, S., Hoecker, P., Fischer, M.B., Jakesz, R., Zeillinger, R., HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer. Oncol. Rep. 14 (2005), 737–741.
86. Jyranoja, B.D., Lund, T., Lea, T., Laland, S.G., On the expression of HMG I protein in quiescent and proliferating human T lymphocytes. Biochem. Int. 24 (1991), 217–223.
87. Meyer, B., Krisponeit, D., Junghanss, C., Murua Escobar, H., Bullerdiek, J., Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count. Leuk. Lymphoma 48 (2007), 2008–2013.
88. Fujikane, R., Komori, K., Sekiguchi, M., Hidaka, M., Function of high-mobility group A proteins in the DNA damage signaling for the induction of apoptosis. Sci. Rep., 6, 2016, 31714.
89. Summer, H., Li, O., Bao, Q., Zhan, L., Peter, S., Sathiyanathan, P., Henderson, D., Klonisch, T., Goodman, S.D., Droge, P., HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy. Nucleic Acids Res. 37 (2009), 4371–4384.
90. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
91. Reeves, R., Edberg, D.D., Li, Y., Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21 (2001), 575–594.
92. Shah, S.N., Cope, L., Poh, W., Belton, A., Roy, S., Talbot, C.C. Jr., Sukumar, S., Huso, D.L., Resar, L.M., HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells. PLoS One, 8, 2013, e63419.
93. Treff, N.R., Dement, G.A., Adair, J.E., Britt, R.L., Nie, R., Shima, J.E., Taylor, W.E., Reeves, R., Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells. Oncogene 23 (2004), 8557–8562.
94. Paonessa, F., Foti, D., Costa, V., Chiefari, E., Brunetti, G., Leone, F., Luciano, F., Wu, F., Lee, A.S., Gulletta, E., Fusco, A., Brunetti, A., Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer. Cancer Res. 66 (2006), 5085–5093.
95. Esposito, F., Tornincasa, M., Chieffi, P., De Martino, I., Pierantoni, G.M., Fusco, A., High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene. Cancer Res. 70 (2010), 5379–5388.
96. Sun, M., Song, C.X., Huang, H., Frankenberger, C.A., Sankarasharma, D., Gomes, S., Chen, P., Chen, J., Chada, K.K., He, C., Rosner, M.R., HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9920–9925.
97. Pegoraro, S., Ros, G., Ciani, Y., Sgarra, R., Piazza, S., Manfioletti, G., A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness. Oncotarget 6 (2015), 19087–19101.
98. Resmini, G., Rizzo, S., Franchin, C., Zanin, R., Penzo, C., Pegoraro, S., Ciani, Y., Piazza, S., Arrigoni, G., Sgarra, R., Manfioletti, G., HMGA1 regulates the plasminogen activation system in the secretome of breast cancer cells. Sci. Rep., 7, 2017, 11768.
99. Camos, S., Gubern, C., Sobrado, M., Rodriguez, R., Romera, V.G., Moro, M.A., Lizasoain, I., Serena, J., Mallolas, J., Castellanos, M., The high-mobility group I–Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins. Neuroscience 269 (2014), 112–130.
100. Messineo, S., Laria, A.E., Arcidiacono, B., Chiefari, E., Luque Huertas, R.M., Foti, D.P., Brunetti, A., Cooperation between HMGA1 and HIF-1 contributes to hypoxia-induced VEGF and visfatin gene expression in 3T3-L1 adipocytes. Front. Endocrinol., 7, 2016, 73.
101. Li, A.Y., Lin, H.H., Kuo, C.Y., Shih, H.M., Wang, C.C., Yen, Y., Ann, D.K., High-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis. Mol. Cell. Biol. 31 (2011), 2605–2617.
102. Willis, S., De, P., Dey, N., Long, B., Young, B., Sparano, J.A., Wang, V., Davidson, N.E., Leyland-Jones, B.R., Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs. Meta Gene 4 (2015), 129–141.
103. Tan, E.J., Kahata, K., Idas, O., Thuault, S., Heldin, C.H., Moustakas, A., The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition. Nucleic Acids Res. 43 (2015), 162–178.
104. Mansueto, G., Forzati, F., Ferraro, A., Pallante, P., Bianco, M., Esposito, F., Iaccarino, A., Troncone, G., Fusco, A., Identification of a new pathway for tumor progression: microRNA-181b up-regulation and CBX7 down-regulation by HMGA1 protein. Genes Cancer 1 (2010), 210–224.
105. Hu, G., Li, L., Xu, W., Extracellular matrix in mammary gland development and breast cancer progression. Frontiers in Laboratory Medicine 1 (2017), 36–39.
106. Baldassarre, G., Belletti, B., Battista, S., Nicoloso, M.S., Pentimalli, F., Fedele, M., Croce, C.M., Fusco, A., HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. Oncogene 24 (2005), 6809–6819.
107. Baldassarre, G., Battista, S., Belletti, B., Thakur, S., Pentimalli, F., Trapasso, F., Fedele, M., Pierantoni, G., Croce, C.M., Fusco, A., Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol. Cell. Biol. 23 (2003), 2225–2238.
108. Boo, L.M., Lin, H.H., Chung, V., Zhou, B., Louie, S.G., O'Reilly, M.A., Yen, Y., Ann, D.K., High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. Cancer Res. 65 (2005), 6622–6630.
109. Li, A.Y., Boo, L.M., Wang, S.Y., Lin, H.H., Wang, C.C., Yen, Y., Chen, B.P., Chen, D.J., Ann, D.K., Suppression of nonhomologous end joining repair by overexpression of HMGA2. Cancer Res. 69 (2009), 5699–5706.
110. Adair, J.E., Maloney, S.C., Dement, G.A., Wertzler, K.J., Smerdon, M.J., Reeves, R., High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. Cancer Res. 67 (2007), 6044–6052.
111. Adair, J.E., Kwon, Y., Dement, G.A., Smerdon, M.J., Reeves, R., Inhibition of nucleotide excision repair by high mobility group protein HMGA1. J. Biol. Chem. 280 (2005), 32184–32192.
112. Heyer, B.S., MacAuley, A., Behrendtsen, O., Werb, Z., Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development. Genes Dev. 14 (2000), 2072–2084.
113. Pellarin, I., Arnoldo, L., Costantini, S., Pegoraro, S., Ros, G., Penzo, C., Triolo, G., Demarchi, F., Sgarra, R., Vindigni, A., Manfioletti, G., The architectural chromatin factor high mobility group A1 enhances DNA ligase IV activity influencing DNA repair. PLoS One, 11, 2016, e0164258.
114. Pentimalli, F., Palmieri, D., Pacelli, R., Garbi, C., Cesari, R., Martin, E., Pierantoni, G.M., Chieffi, P., Croce, C.M., Costanzo, V., Fedele, M., Fusco, A., HMGA1 protein is a novel target of the ATM kinase. Eur. J. Cancer 44 (2008), 2668–2679.
115. D'Angelo, D., Mussnich, P., Rosa, R., Bianco, R., Tortora, G., Fusco, A., High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs. BMC Cancer, 14, 2014, 851.
116. Reeves, R., High mobility group (HMG) proteins: modulators of chromatin structure and DNA repair in mammalian cells. DNA Repair (Amst) 36 (2015), 122–136.
117. Wei, M.L., Duan, P., Wang, Z.M., Ding, M., Tu, P., High glucose and high insulin conditions promote MCF7 cell proliferation and invasion by upregulating IRS1 and activating the Ras/Raf/ERK pathway. Mol. Med. Rep. 16 (2017), 6690–6696.
118. Kocdor, M.A., Kocdor, H., Pereira, J.S., Vanegas, J.E., Russo, I.H., Russo, J., Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 15 (2013), 55–64.
119. Ha, T.K., Her, N.G., Lee, M.G., Ryu, B.K., Lee, J.H., Han, J., Jeong, S.I., Kang, M.J., Kim, N.H., Kim, H.J., Chi, S.G., Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res. 72 (2012), 4097–4109.
120. Schwab, M., Encyclopedia of Cancer. 2017.
121. Goldfine, I.D., The insulin receptor: molecular biology and transmembrane signaling. Endocr. Rev. 8 (1987), 235–255.
122. Brunetti, A., Manfioletti, G., Chiefari, E., Goldfine, I.D., Foti, D., Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J. 15 (2001), 492–500.
123. Foti, D., Iuliano, R., Chiefari, E., Brunetti, A., A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol. Cell. Biol. 23 (2003), 2720–2732.
124. Costa, V., Foti, D., Paonessa, F., Chiefari, E., Palaia, L., Brunetti, G., Gulletta, E., Fusco, A., Brunetti, A., The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists. Endocr. Relat. Cancer 15 (2008), 325–335.
125. Aiello, A., Pandini, G., Sarfstein, R., Werner, H., Manfioletti, G., Vigneri, R., Belfiore, A., HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene. Eur. J. Cancer 46 (2010), 1919–1926.
126. Iiritano, S., Chiefari, E., Ventura, V., Arcidiacono, B., Possidente, K., Nocera, A., Nevolo, M.T., Fedele, M., Greco, A., Greco, M., Brunetti, G., Fusco, A., Foti, D., Brunetti, A., The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake. Mol. Endocrinol. 26 (2012), 1578–1589.
127. Werner, H., Sarfstein, R., Transcriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancer. Growth Hormone & IGF Research: Official Journal Of The Growth Hormone Research Society and the International IGF Research Society 24 (2014), 112–118.
128. Arcidiacono, B., Iiritano, S., Chiefari, E., Brunetti, F.S., Gu, G., Foti, D.P., Brunetti, A., Cooperation between HMGA1, PDX-1, and MafA is essential for glucose-induced insulin transcription in pancreatic beta cells. Front. Endocrinol., 5, 2014, 237.
129. Chiefari, E., Nevolo, M.T., Arcidiacono, B., Maurizio, E., Nocera, A., Iiritano, S., Sgarra, R., Possidente, K., Palmieri, C., Paonessa, F., Brunetti, G., Manfioletti, G., Foti, D., Brunetti, A., HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci. Rep., 2, 2012, 251.
130. Martinez Hoyos, J., Fedele, M., Battista, S., Pentimalli, F., Kruhoffer, M., Arra, C., Orntoft, T.F., Croce, C.M., Fusco, A., Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res. 64 (2004), 5728–5735.
131. Arcidiacono, B., Chiefari, E., Messineo, S., Bilotta, F.L., Pastore, I., Corigliano, D.M., Foti, D.P., Brunetti, A., HMGA1 is a novel transcriptional regulator of the FoxO1 gene. Endocrine, 2017, 10.1007/s12020-017-1445-8.
132. Bianconcini, A., Lupo, A., Capone, S., Quadro, L., Monti, M., Zurlo, D., Fucci, A., Sabatino, L., Brunetti, A., Chiefari, E., Gottesman, M.E., Blaner, W.S., Colantuoni, V., Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1). Int. J. Biochem. Cell Biol. 41 (2009), 2189–2203.
133. Chiefari, E., Paonessa, F., Iiritano, S., Le Pera, I., Palmieri, D., Brunetti, G., Lupo, A., Colantuoni, V., Foti, D., Gulletta, E., De Sarro, G., Fusco, A., Brunetti, A., The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol., 7, 2009, 24.
134. Melillo, R.M., Pierantoni, G.M., Scala, S., Battista, S., Fedele, M., Stella, A., De Biasio, M.C., Chiappetta, G., Fidanza, V., Condorelli, G., Santoro, M., Croce, C.M., Viglietto, G., Fusco, A., Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol. Cell. Biol. 21 (2001), 2485–2495.
135. Pullinger, C.R., Goldfine, I.D., Tanyolac, S., Movsesyan, I., Faynboym, M., Durlach, V., Chiefari, E., Foti, D.P., Frost, P.H., Malloy, M.J., Brunetti, A., Kane, J.P., Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population. Metab. Syndr. Relat. Disord. 12 (2014), 25–30.
136. Dement, G.A., Treff, N.R., Magnuson, N.S., Franceschi, V., Reeves, R., Dynamic mitochondrial localization of nuclear transcription factor HMGA1. Exp. Cell Res. 307 (2005), 388–401.
137. Mao, L., Wertzler, K.J., Maloney, S.C., Wang, Z., Magnuson, N.S., Reeves, R., HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiency. Mol. Cell. Biol. 29 (2009), 5426–5440.
138. Dement, G.A., Maloney, S.C., Reeves, R., Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. Exp. Cell Res. 313 (2007), 77–87.
139. Dolde, C.E., Mukherjee, M., Cho, C., Resar, L.M., HMG-I/Y in human breast cancer cell lines. Breast Cancer Res. Treat. 71 (2002), 181–191.
140. Scheel, C., Weinberg, R.A., Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22 (2012), 396–403.
141. Thuault, S., Tan, E.J., Peinado, H., Cano, A., Heldin, C.H., Moustakas, A., HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J. Biol. Chem. 283 (2008), 33437–33446.
142. Di Cello, F., Shin, J., Harbom, K., Brayton, C., Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice. Biochem. Biophys. Res. Commun. 434 (2013), 70–74.
143. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., Campbell, L.L., Polyak, K., Brisken, C., Yang, J., Weinberg, R.A., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008), 704–715.
144. Morishita, A., Zaidi, M.R., Mitoro, A., Sankarasharma, D., Szabolcs, M., Okada, Y., D'Armiento, J., Chada, K., HMGA2 is a driver of tumor metastasis. Cancer Res. 73 (2013), 4289–4299.
145. Wood, L.J., Maher, J.F., Bunton, T.E., Resar, L.M., The oncogenic properties of the HMG-I gene family. Cancer Res. 60 (2000), 4256–4261.
146. Ringner, M., Fredlund, E., Hakkinen, J., Borg, A., Staaf, J., GOBO: gene expression-based outcome for breast cancer online. PLoS One, 6, 2011, e17911.